DK0768892T3 - Thrombolytisk præparat - Google Patents

Thrombolytisk præparat

Info

Publication number
DK0768892T3
DK0768892T3 DK95924413T DK95924413T DK0768892T3 DK 0768892 T3 DK0768892 T3 DK 0768892T3 DK 95924413 T DK95924413 T DK 95924413T DK 95924413 T DK95924413 T DK 95924413T DK 0768892 T3 DK0768892 T3 DK 0768892T3
Authority
DK
Denmark
Prior art keywords
pct
native
sec
thrombolytic
date
Prior art date
Application number
DK95924413T
Other languages
English (en)
Inventor
Keith Martyn Dawson
Lars Michael Wood
Michael Berisford Comer
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Application granted granted Critical
Publication of DK0768892T3 publication Critical patent/DK0768892T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21068—Tissue plasminogen activator (3.4.21.68), i.e. tPA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK95924413T 1994-06-17 1995-06-14 Thrombolytisk præparat DK0768892T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9412131A GB9412131D0 (en) 1994-06-17 1994-06-17 Thrombolytic composition
PCT/GB1995/001388 WO1995035117A1 (en) 1994-06-17 1995-06-14 Thrombolytic composition

Publications (1)

Publication Number Publication Date
DK0768892T3 true DK0768892T3 (da) 2004-03-15

Family

ID=10756864

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95924413T DK0768892T3 (da) 1994-06-17 1995-06-14 Thrombolytisk præparat

Country Status (10)

Country Link
US (1) US5741771A (da)
EP (1) EP0768892B1 (da)
JP (1) JP3690803B2 (da)
AT (1) ATE253937T1 (da)
DE (1) DE69532123T2 (da)
DK (1) DK0768892T3 (da)
ES (1) ES2210298T3 (da)
GB (1) GB9412131D0 (da)
PT (1) PT768892E (da)
WO (1) WO1995035117A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264809B1 (en) * 1998-10-16 2007-09-04 Immunex Corporation Methods of inhibiting platelet activation and recruitment
US6797820B2 (en) * 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
RU2216348C1 (ru) * 2002-11-14 2003-11-20 Общество с ограниченной ответственностью "Научно-производственное предприятие "Техноген" Фармацевтическая композиция, обладающая тромболитическим и фибринолитическим действием
US20080057050A1 (en) * 2003-05-02 2008-03-06 Paion Deutschland Gmbh Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
US20060135425A1 (en) * 2003-05-02 2006-06-22 Paion Deutschland Gmbh Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
TWI482628B (zh) * 2007-10-18 2015-05-01 Lundbeck & Co As H 新穎之血栓溶解病患次群

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2764264B2 (ja) * 1987-10-01 1998-06-11 株式会社ミドリ十字 線溶活性増強剤
US5087572A (en) * 1989-12-01 1992-02-11 Genentech, Inc. Dna encoding human plasminogen modified at the cleavage site
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5688664A (en) * 1990-12-07 1997-11-18 British Bio-Technology Ltd. Thrombin activatable plasminogen analogues
GB9222758D0 (en) * 1992-10-29 1992-12-09 British Bio Technology Proteins and nucleic acids
WO1994001128A1 (en) * 1992-07-01 1994-01-20 Beth Israel Hospital Boston Enhancement of thrombolytic therapy with deglycosylated plasminogen
GB9216558D0 (en) * 1992-08-04 1992-09-16 British Bio Technology Modified proteases
DK125693D0 (da) * 1993-11-05 1993-11-05 Novo Nordisk As

Also Published As

Publication number Publication date
DE69532123D1 (de) 2003-12-18
PT768892E (pt) 2004-04-30
JP3690803B2 (ja) 2005-08-31
JPH10501548A (ja) 1998-02-10
DE69532123T2 (de) 2004-08-26
ATE253937T1 (de) 2003-11-15
US5741771A (en) 1998-04-21
GB9412131D0 (en) 1994-08-10
EP0768892B1 (en) 2003-11-12
WO1995035117A1 (en) 1995-12-28
EP0768892A1 (en) 1997-04-23
ES2210298T3 (es) 2004-07-01

Similar Documents

Publication Publication Date Title
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
CY1107995T1 (el) ΑΝΑΣΤΟΛΗ ΔΡΑΣΤΙΚΟΤΗΤΑΣ p38 ΚΙΝΑΣΗΣ ΧΡΗΣΙΜΟΠΟΙΩΝΤΑΣ ΑΡΥΛ ΚΑΙ ΕΤEPΟΑΡΥΛ ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΤEPΟΚΥΚΛΙΚΕΣ ΟΥΡΙΕΣ
GEP20012448B (en) Tissue Plasminogen Activators (Improved Variants)
DE60139078D1 (de) Plasminogen aktivator zur verhinderung von horn- und subepithelialeintrübung nach laser-sehkraftkorrektur-chirurgie
IL205695A0 (en) Compositions containing dspa alpha 1 for the treatment of stroke
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
FI925787A0 (fi) Proteolytiska enzymers sackarinderivatinhibitorer
DK0768892T3 (da) Thrombolytisk præparat
ATE82127T1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
ATE179164T1 (de) Hiv-proteaseinhibitoren
DK2359853T3 (da) Farmaceutiske sammensætninger og fremgangsmåder, der er anvendelige til at modulere antiogenese
AU4502589A (en) Thrombolytic agents with modified kringle domains
ATE103178T1 (de) T-pa pro stabilisierung.
ATE171213T1 (de) Plasminogen-derivate die durch thrombin aktivierbar sind
ATE80308T1 (de) Thrombotische zusammensetzungen.
GB8928811D0 (en) An activator for damaged neurocytes for the prevention and treatment of disease